Skip to main content



Our goal is facilitating access to drugs throughout all their phases (authorized and not yet authorized drugs), by helping pharma companies extend their product distribution in markets where they are not present yet.
eXinvest Pharmaceuticals’ mission is placing its experience and intuitions at the service of pharma companies and field operators, to meet new patients’ needs through innovative offers and new distribution paths. We are constantly looking for new and promising pharmaceutical and biotech companies to work with, to develop new licences and market new drugs, thanks to our exclusive distribution network leads. We are active in many Countries, including Switzerland, Italy, UAE, Bosnia, Argentina, Libya, Lebanon, Iran, Iraq, Syria, Tunisia, Germany and UK.

Authorized Drugs

Concerning authorized drugs, eXinvest Pharmaceuticals signs agreement with pharmaceutical and biotech manufacturers to provide access and distribution services of new drugs on new and promising markets, by managing their commercial launch.

In case of drugs of treatments not yet authorized, we can support companies throughout this delicate transition, in order to strengthen the value and prospects for success of a drug even further, through Regulation, Marketing, Sales, Distribution, Market Access, Price and Refund Definition activities.

Drugs Without Licence

eXinvest Pharmaceuticals can provide pharmaceutical products in territories where they are not yet available, by offering paid access to new treatments or products with shortage of supplies.

Launch of Innovative Product
It could take months or years to approve new drugs, and patients are not always able to wait. And eXor Pharmaceuticals can help introduce – in certain market – products that can meet the patients’ unsatisfied needs. We can do this through national Named Patient regulatory paths and consolidated strategies.
Consolidated Products with Insufficient Supplies

The majority of hospitals in the EU reports severe drugs shortages, and this truly impacts patients’ health and care. In those cases, offering an alternative treatment with drugs without licence available in other Countries is really important. eXinvest Pharmaceuticals can offer this kind of consultancy and support, thanks to its connections with global manufacturers and suppliers, thus ensuring continuous and safe supply of valid alternative treatments.

Market Exit

Sometimes, under certain circumstances, a drug may no longer be available on the market. In this case, eXinvest Pharmaceuticals can intervene by promptly suggesting alternative distribution solutions, so that patients are not obliged to give up their treatment, and can continue to have access to the required drug.

Managed Access Programs

In those Countries and markets where a drug has yet to be launched and distributed, eXinvest Pharmaceuticals can help companies provide their products through managed access programs and Named Patient Supply services. Operators looking for an ethical access to treatments that are not available in a certain market, can resort to our distribution network and our global references.


Pharmaceutical and Biotech Companies
eXinvest Pharmaceuticals can help pharmaceutical and biotech companies launch new drugs in new markets, by supervising the entire product and distribution life cycle, thanks to their experience and scouting skills.
Healthcare Providers
We can support healthcare providers, doctors, hospitals, clinics and pharmacies all over the world, which often must face the absence of authorized treatments. Through our interventions, and our ability to understand and manage local regulations, we can meet drug supply expectations, even for unlicensed drugs. It is a constant challenge to try and overcome the lack of drugs and treatments, by intervening with utmost efficiency and urgency.
Patient Representatives Groups
Through Patient Representatives Groups, it is possible to gain access to unlicensed drugs, which, in most cases, are the only option for a patient, when there is no other treatment available in their Country of origin. eXinvest Pharmaceuticals is available to work with these groups, to provide prompt and accurate information on the possibility to have access to unlicensed drugs.


Individual Patients: eXinvest Pharmaceuticals cannot deal directly and personally with private patients. In this case, we suggest you contact a healthcare support provider (Doctor, Pharmacist, Hospital) to discuss with them any access options to the required treatment or any possible alternatives.


eXinvest Pharmaceuticals is a global authorized distributor with Swiss Medic License.
Our facilities and our staff fully comply with EU, Swiss and Liechtenstein PIL guidelines.

We can promptly meet the field needs and requirements, by suggesting new or existing treatments, in an ethic and reliable way, and in compliance with the regulations in force in the different Countries.

We offer innovative and consolidated supply, transport, delivery and storage solutions for any kind of treatment. The product is preserved during the entire distribution chain.

Patients are Our Core

First and foremost, eXinvest Pharmaceuticals aims at helping patients and their families meet new medical needs, to ensure their health and well-being.

Respect for Life

We value the life of every human being. Both patients’, to whom we want to offer the most cutting-edge therapies, and our employees’, to whom we ensure workplace safety and career opportunities.

Customizes Solutions

Through our work, we want to strive for excellence and generate added value for all our customers, by looking for customized solutions that meet the different needs of our partners.
Contact Us
In eXinvest board, you will find business persons, Swiss and foreign accountants, and partners of subsidiaries or associate companies, as members and attorneys.